New Recommendation on adult pneumococcal vaccination in the UK

United Kingdom
4 December 2015

During 2015 the Joint Committee on Vaccination and Immunisation (JCVI) and its pneumococcal sub-committee have reviewed the adult pneumococcal vaccination programme. This interim position statement outlines JCVI’s considerations. The committee will consult stakeholders before producing a final statement.

uk.png

The recommendation is available here.

Documents to download

Related News & Events

  • United Kingdom

    JCVI recommends to extend vaccination against HPV to boys

    18.07.2018

    The Joint Committee on Vaccination and Immunisations (JCVI) has recommended that the HPV immunisation programme should be extended to cover boys.

    Read more
  • United Kingdom

    JCVI says YES to LAIV for preventing flu in children

    30.08.2016

    In August 2016, JCVI was asked to review updated data from the 2015/16 season in the UK and other countries, in light of emerging evidence of low effectiveness of the nasal spray vaccine, lower than inactivated vaccine, reported in the United States (US). After reviewing evidence from across the UK, Finland, Canada and the United States following the 2015/16 influenza season, much of which demonstrates good overall effectiveness, JCVI continues to recommend using the live attenuated influenza vaccine (LAIV, the nasal spray vaccine) for preventing flu in children and strongly supports the continuation of the UK childhood influenza immunisation programme. 

    Read more
  • United Kingdom

    JCVI October meeting agenda

    06.10.2015

    The JCVI is holding its last meeting of the year 2015 on October 7th in Skipton House, London. 

     

    Read more